I. ARTICLES

How a Drug Becomes “Ethnic”: Law, Commerce, and the Production of Racial Categories in Medicine
Jonathan Kahn, J.D., Ph.D.

(How) Is Aging a Health Policy Problem?
Joseph White, Ph.D.

Pharmaceutical Research and Manufacturers of America v. Walsh: The Supreme Court Allows the States To Proceed with Expanding Access to Drugs
Timothy Stoltzfus Jost, J.D

II. NOTE

New Diagnoses and the ADA: A Case Study of Fibromyalgia and Multiple Chemical Sensitivity
Ruby Afram

III. CASE STUDY

How Can Resources Be Mobilized To Confront a Global Health Emergency?

Responses by:


U.N. Special Envoy Stephen Lewis
Asia Russell
Linda M. Distlerath, Ph.D. and Guy Macdonald
Mary Crewe

IV. BOOK REVIEWS

The High Cost of Prescription Drugs: The Price of Success?
H. Jeffrey Lawrence, M.D.

American Meat: A Threat to Your Health and to the Environment
Polly Walker, M.D., M.P.H. and Robert S. Lawrence, M.D.

©2002 by the Yale Law School. All rights reserved.